BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16740372)

  • 1. Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate.
    Groeschke J; Solassol I; Bressolle F; Pinguet F
    J Pharm Biomed Anal; 2006 Sep; 42(3):362-6. PubMed ID: 16740372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of in vitro activity and stability of antifungal suspensions for mouthrinses: to a reappraisal of empiric practices?].
    Jolivot PA; Dunyach-Remy C; Roussey A; Jalabert A; Mallié M; Hansel-Esteller S
    Pathol Biol (Paris); 2012 Dec; 60(6):362-8. PubMed ID: 22361161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of nystatin in mouthrinses; effect of pH temperature, concentration and colloidal silver addition, studied using an in vitro antifungal activity.
    Vermerie N; Malbrunot C; Azar M; Arnaud P
    Pharm World Sci; 1997 Aug; 19(4):197-201. PubMed ID: 9297733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Photostability of antifungal agents. 2. Photostability of polyene antibiotics].
    Thoma K; Kübler N
    Pharmazie; 1997 Apr; 52(4):294-302. PubMed ID: 9190607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability.
    Morand K; Bartoletti AC; Bochot A; Barratt G; Brandely ML; Chast F
    Int J Pharm; 2007 Nov; 344(1-2):150-3. PubMed ID: 17669608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based antifungal agents: a concise overview.
    Arikan S
    Cell Mol Biol Lett; 2002; 7(3):919-22. PubMed ID: 12378276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New liposomal forms of antifungal antibiotics, modified by amphiphilic polymers].
    Iamskov IA; Kuskov AN; Babievskiĭ KK; Berezin BB; Kraiukhina MA; Samoĭlova NA; Tikhonov VE; Shtil'man MI
    Prikl Biokhim Mikrobiol; 2008; 44(6):688-93. PubMed ID: 19145977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous line.
    Kintzel PE; Kennedy PE
    Am J Hosp Pharm; 1991 Feb; 48(2):283-5. PubMed ID: 2003501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the post-antifungal effect (PAFE) of amphotericin B and nystatin against 30 zygomycetes using two different media.
    Vitale RG; Meis JF; Mouton JW; Verweij PE
    J Antimicrob Chemother; 2003 Jul; 52(1):65-70. PubMed ID: 12775672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of nystatin and amphotericin analogues: characterisation of minor anti-fungal macrolides.
    Ulrych A; Derrick PJ; Adamek F; Novák P; Lemr K; Havlicek V
    Eur J Mass Spectrom (Chichester); 2010; 16(1):73-80. PubMed ID: 20065516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two mutants selectively resistant to polyenes reveal distinct mechanisms of antifungal activity by nystatin and amphotericin B.
    Hapala I; Klobucníková V; Mazánová K; Kohút P
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1206-9. PubMed ID: 16246082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stability testing of amphotericin B nasal spray solutions with chemical and biological analysis].
    Fittler A; Mayer A; Kocsis B; Gerlinger I; Fónay F; Botz L
    Acta Pharm Hung; 2007; 77(3):159-64. PubMed ID: 18019780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of amphotericin B in an extemporaneously prepared i.v. fat emulsion.
    Lopez RM; Ayestaran A; Pou L; Montoro JB; Hernandez M; Caragol I
    Am J Health Syst Pharm; 1996 Nov; 53(22):2724-7. PubMed ID: 8931814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, physico-chemical and biological properties of some alkali metals and quaternary alkylammonium salts of polyene antibiotics: amphotericin B, nystatin and aureofungin.
    Chatterjee NR; Badave VM; Pawar DA
    Hindustan Antibiot Bull; 1994; 36(1-2):34-8. PubMed ID: 7737895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical guidelines for preparing and administering amphotericin B.
    Kintzel PE; Smith GH
    Am J Hosp Pharm; 1992 May; 49(5):1156-64. PubMed ID: 1595747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted antifungal delivery system: beta-glucosidase sensitive nystatin-star poly(ethylene glycol) conjugate.
    Bílková E; Imramovský A; Buchta V; Sedlák M
    Int J Pharm; 2010 Feb; 386(1-2):1-5. PubMed ID: 19874880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy.
    Epstein JB; Truelove EL; Hanson-Huggins K; Mancl LA; Chen A; Press OW; Petersdorf SH; Fritsche TR; Epstein JD
    Support Care Cancer; 2004 Jul; 12(7):517-25. PubMed ID: 15108100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conventional treatment of oral candidiasis--new aspects].
    Barkvoll P; Hurlen B
    Nor Tannlaegeforen Tid; 1989 Feb; 99(4):116-9. PubMed ID: 2626320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemical and microbiological aspects of the quantitative analysis of amphotericin B].
    Fittler A; Matus Z; Kocsis B; Botz L
    Acta Pharm Hung; 2008; 78(3):95-102. PubMed ID: 18986086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High purity amphotericin B.
    Cleary JD; Chapman SW; Swiatlo E; Kramer R
    J Antimicrob Chemother; 2007 Dec; 60(6):1331-40. PubMed ID: 17921178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.